Jimmy T. Wangdi, Mary F. O’Leary, Vincent G. Kelly, Jonathan C. Y. Tang, Joanna L. Bowtell
{"title":"Montmorency cherry supplementation enhances 15 km cycling time trial performance: Optimal timing 90-min pre-exercise","authors":"Jimmy T. Wangdi, Mary F. O’Leary, Vincent G. Kelly, Jonathan C. Y. Tang, Joanna L. Bowtell","doi":"10.1002/ejsc.12187","DOIUrl":null,"url":null,"abstract":"<p>Montmorency cherry (MC) can improve endurance performance, but optimal pre-exercise timing of supplementation and influence of training status on efficacy are unknown. We investigated the effect of MC concentrate ingestion between 30- and 150-min pre-exercise in trained and recreational cyclists on 15-km time trial (TT) performance and exercise economy. Twenty participants (10 recreationally active, RA; 10 trained, T) completed 10 min of steady-state exercise (SSE) at 40%Δ (SSE) and a TT on four separate occasions following an unsupplemented (US), 30-, 90- or 150-min pre-exercise Montmorency cherry concentrate (MCC) supplementation conditions (MCC<sup>30/90/150min</sup>). Venous and capillary blood samples were taken at regular intervals pre- and post-SSE and TT. MCC significantly improved TT performance, but not exercise economy. The greatest improvement in performance occurred following MCC<sup>90min</sup> compared to US (US 1603.1 ± 248 s vs. MCC<sup>90min</sup> 1554.8 ± 226.7 s, 2.83% performance improvement). Performance was significantly enhanced for trained (US 1496.6 ± 173.1 s vs. MCC<sup>90min</sup> 1466.8 ± 157.6 s) but not recreationally active participants. Capillary [lactate] and heart rate were significantly greater during the TT for the 90-min dose timing (<i>p</i> < 0.05). In the MCC<sup>30min</sup> and MCC<sup>90min</sup> conditions, plasma ferulic (US 8.71 ± 3.22 nmol. L<sup>−1</sup> vs. MCC<sup>30min</sup> 15.80 ± 8.69 nmol. L<sup>−1</sup>, MCC<sup>90min</sup> 12.65 ± 4.84 nmol. L<sup>−1</sup>) and vanillic acid (US 25.14 ± 10.91 nmol.L<sup>−1</sup> vs. MCC<sup>30min</sup> 153.07 ± 85.91 nmol. L<sup>−1</sup>, MCC<sup>90min</sup> 164.58 ± 59.06 nmol. L<sup>−1</sup>) were significantly higher pre-exercise than in US and MCC<sup>150min</sup> conditions (<i>p</i> < 0.05). There was no significant change in muscle oxygenation status or plasma nitrite/nitrate concentration. MCC supplementation enhanced endurance exercise performance optimally when consumed ∼90 min pre-exercise producing maximal plasma phenolic metabolites during exercise. The ergogenic effect was greater for trained participants.</p>","PeriodicalId":93999,"journal":{"name":"European journal of sport science","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11451560/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of sport science","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ejsc.12187","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Montmorency cherry (MC) can improve endurance performance, but optimal pre-exercise timing of supplementation and influence of training status on efficacy are unknown. We investigated the effect of MC concentrate ingestion between 30- and 150-min pre-exercise in trained and recreational cyclists on 15-km time trial (TT) performance and exercise economy. Twenty participants (10 recreationally active, RA; 10 trained, T) completed 10 min of steady-state exercise (SSE) at 40%Δ (SSE) and a TT on four separate occasions following an unsupplemented (US), 30-, 90- or 150-min pre-exercise Montmorency cherry concentrate (MCC) supplementation conditions (MCC30/90/150min). Venous and capillary blood samples were taken at regular intervals pre- and post-SSE and TT. MCC significantly improved TT performance, but not exercise economy. The greatest improvement in performance occurred following MCC90min compared to US (US 1603.1 ± 248 s vs. MCC90min 1554.8 ± 226.7 s, 2.83% performance improvement). Performance was significantly enhanced for trained (US 1496.6 ± 173.1 s vs. MCC90min 1466.8 ± 157.6 s) but not recreationally active participants. Capillary [lactate] and heart rate were significantly greater during the TT for the 90-min dose timing (p < 0.05). In the MCC30min and MCC90min conditions, plasma ferulic (US 8.71 ± 3.22 nmol. L−1 vs. MCC30min 15.80 ± 8.69 nmol. L−1, MCC90min 12.65 ± 4.84 nmol. L−1) and vanillic acid (US 25.14 ± 10.91 nmol.L−1 vs. MCC30min 153.07 ± 85.91 nmol. L−1, MCC90min 164.58 ± 59.06 nmol. L−1) were significantly higher pre-exercise than in US and MCC150min conditions (p < 0.05). There was no significant change in muscle oxygenation status or plasma nitrite/nitrate concentration. MCC supplementation enhanced endurance exercise performance optimally when consumed ∼90 min pre-exercise producing maximal plasma phenolic metabolites during exercise. The ergogenic effect was greater for trained participants.